ArticleBMC neurology2026
Pediatric Migraine Disability Assessment (PedMIDAS): translation into Turkish and cross-cultural adaptation.
Article in BMC neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Pediatric Migraine Disability Assessment (PedMIDAS) questionnaire is widely used to evaluate migraine-related disability in children and adolescents. The aim of this study was to assess the validity and test-retest reliability of the Turkish version of the PedMIDAS.
methodsThe PedMIDAS was translated into Turkish using a forward-backward translation procedure. A total of 60 children and adolescents diagnosed with migraine participated in this cross-sectional study. Data collection was conducted in two sessions separated by 15 days. During the first session, sociodemographic information and migraine characteristics, including attack frequency, duration, and pain severity assessed by the visual analogue scale (VAS), were recorded. Participants also completed the Turkish PedMIDAS and the Child Self-Report form of the Pediatric Quality of Life Inventory™ 4.0 (PedsQL™) to evaluate convergent validity. Fifteen days later, the participants completed the Turkish PedMIDAS again to assess test-retest reliability.
resultsThe Turkish version of the PedMIDAS demonstrated acceptable internal consistency (α = 0.74) and strong test-retest reliability (r = 0.92). PedMIDAS scores were significantly associated with migraine clinical characteristics and quality-of-life measures.
conclusionThe Turkish version of the PedMIDAS is a valid and reliable instrument for assessing migraine-related disability in children and adolescents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.